INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)	3 Months Ended		9 Months Ended		219 Months Ended
	Apr. 30, 2014	Apr. 30, 2013	Apr. 30, 2014	Apr. 30, 2013	Apr. 30, 2014
Income Statement [Abstract]
Revenues, net					$ 5,110,784
Cost of Goods Sold					1,620,375
Gross profit					3,490,409
Operating Expenses:
Research and development	348,104	478,110	1,097,877	1,631,987	135,266,565
Research and development - related party					220,218
Selling and marketing					9,333,214
General and administrative	894,745	955,530	2,598,884	3,032,464	154,337,675
General and administrative - related party					314,328
Total Operating Expenses	1,242,849	1,433,640	3,696,761	4,664,451	299,472,000
Operating Loss	(1,242,849)	(1,433,640)	(3,696,761)	(4,664,451)	(295,981,591)
Other Income (Expense):
Miscellaneous income					686,303
Income from assets held for investment, net (Note 11)		126,701	193,607	1,210,567	5,773,029
Interest income	523	22	569	329	7,782,815
Interest expense	(78,126)	(86,421)	(243,506)	(453,677)	(69,782,410)
Change in fair value of derivative liabilities (Note 10)	1,591,375	2,690,786	1,360,818	(1,092,504)	(2,495,418)	[1]
Loss on extinguishment of debt					(14,134,068)
Net Income/(Loss) Before Undernoted	270,923	1,297,448	(2,385,273)	(4,999,736)	(368,151,340)
Minority Interest Share of Loss					3,038,185
Net Income/(Loss) (Note 4)	270,923	1,297,448	(2,385,273)	(4,999,736)	(365,113,155)
Preferred Stock Dividend (Note 9)	1,420,050		1,828,329	102,297	6,989,023
Net Income/(Loss) Available to Common Stockholders	$ (1,149,127)	$ 1,297,448	$ (4,213,602)	$ (5,102,033)	$ (372,102,178)
Net Income/(Loss) Per Common Share (Note 8) (in dollars per share)
Basic	$ (0.002)	$ 0.003	$ (0.006)	$ (0.012)
Diluted	$ (0.002)	$ 0.002	$ (0.006)	$ (0.012)
Shares Used to Compute Earnings/(Loss) per Share (Note 8)
Basic	727,041,541	491,220,657	649,133,385	413,135,599
Diluted	727,041,541	713,150,718	649,133,385	413,135,599

[1] Includes $5,981,403 as adjustment related to the adoption of FASB ASC Topic 815 in "Cumulative from November 2, 1995 (Date of Inception) to January 31, 2014" column. See Note 10 - Derivative Warrant Liability.